While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

While charitable dollars have flowed in to plug some gaps, “philanthropy cannot replace federal funding,” said Dustin Sposato ...

Democrats in the U.S. Senate slammed Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for cutting biomedical research and public health programs at the committee hearing.

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

"With the COVID pandemic behind us, it is time to adopt a common-sense approach to COVID policy," a spokesperson for the FDA ...

The FDA’s new approach to boosters could mean that kids will no longer be able to get vaccinated against the disease to begin with.

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into ...

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.